Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns
Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney
LESSONS LEARNED FROM COVID-19 – POLICY PAPER
Position Paper. Reference safety information: challenges to the generic industry due to labelling harmonisation issues among different Member States
The secret to improve access to value added medicines
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
